Skip to main content
Clinical Trials/NCT04108299
NCT04108299
Completed
N/A

Feasibility of a Family-oriented mHealth Intervention for Chinese Americans With Type 2 Diabetes

NYU Langone Health1 site in 1 country46 target enrollmentApril 21, 2021
ConditionsType 2 Diabetes

Overview

Phase
N/A
Intervention
Not specified
Conditions
Type 2 Diabetes
Sponsor
NYU Langone Health
Enrollment
46
Locations
1
Primary Endpoint
Percentage of Videos Watched by Participants
Status
Completed
Last Updated
last year

Overview

Brief Summary

The goal of this pilot study is to examine the feasibility and acceptability of a family-oriented SMS intervention in 30 Chinese Americans with T2D and their family members. Participants will be randomized to one of 2 arms (n=15 each): 1) wait-list control and 2) SMS intervention. Both groups will continue to receive standard of care treatment for their T2D. The SMS group will receive brief lifestyle counseling videos via SMS links. At the end of the study, the wait-list control group will be provided the opportunity to receive the counseling videos.

Detailed Description

Chinese Americans are one of the fastest growing immigrant groups in the US, who suffer disproportionately high type 2 diabetes (T2D) burden and have poorly controlled T2D. Given the high economic and societal burden of T2D and rapid population growth in Chinese Americans, there is an urgent need for research to develop effective interventions to address T2D burden in this population. Recent evidence suggests the importance of involving and empowering family members in diabetes intervention and calls for family intervention. A mobile health approach such as short message service (SMS) might be a promising way to deliver such family-oriented interventions to the target population given prior studies suggests that Chinese Americans often report challenges to attend in-person lifestyle counseling because of long working hours and lack of sick time from work. A SMS-based intervention provides the flexibility of allowing them to view the intervention at a time and place convenient to them. This study will serve as the first step to explore an alternative approach for managing T2D in this group.

Registry
clinicaltrials.gov
Start Date
April 21, 2021
End Date
July 30, 2022
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria for patient participants:
  • self-identify as Chinese or Chinese American;
  • be between the ages of 18 and 70,
  • self-report a diagnosis of T2D;
  • be willing to receive WeChat messages regarding T2D management,
  • possess a smartphone or be willing and able to use a study smartphone. If participants have their own smartphones, they are encouraged to use their own phones. For participants who do not have smartphones, the study will provide them
  • has a family member or friend be willing to participate in the study to learn about T2D to better support them
  • Inclusion criteria for family/friend participants: family/friend participants must
  • be between 18-70 years old,
  • be willing to receive WeChat messages regarding T2D management

Exclusion Criteria

  • Exclusion criteria for both patient and family/friend participants:
  • unable or unwilling to provide informed consent;
  • unable to participate meaningfully in the intervention (e.g., uncorrected sight and hearing impairment);
  • unwilling to accept randomization assignment;
  • pregnant, plans to becomes pregnant in the next 6 months, or who become pregnant during the study, or
  • breastfeeding.

Outcomes

Primary Outcomes

Percentage of Videos Watched by Participants

Time Frame: Up to Month 6

Measure of SMS intervention feasibility.

Satisfaction Questionnaire Score

Time Frame: Month 6

1-item assessment of satisfaction with the SMS intervention. The item is rated on a scale from 0 (not at all satisfied) to 10 (totally satisfied). The total score is the numerical response; higher scores indicate greater satisfaction.

Secondary Outcomes

  • Change in Body Weight(Baseline, Month 6)
  • Change in Summary of Diabetes Self-Care Activities (SDSCA) Score(Baseline, Month 6)
  • Change in Mediterranean Dietary Screener (MEDAS) - Fruit Score(Baseline, Month 6)
  • Change in Mediterranean Dietary Screener (MEDAS) - Whole Wheat Score(Baseline, Month 6)
  • Change in Mediterranean Dietary Screener (MEDAS) - Refined Grains Score(Baseline, Month 6)
  • Change in Diabetes Management Self-Efficacy Scale (DMSES) Score(Baseline, Month 6)
  • Change in Mediterranean Dietary Screener (MEDAS) - Starchy Score(Baseline, Month 6)
  • Change in HbA1c Level(Baseline, Month 6)
  • Change in Diabetes Knowledge Test Scores(Baseline, Month 6)
  • Change in International Physical Activity Questionnaire (IPAQ)-Short Version MET Score(Baseline, Month 6)
  • Change in Mediterranean Dietary Screener (MEDAS) - Vegetable Score(Baseline, Month 6)
  • Change in the Patient Reported Outcome Measurement Information System (PROMIS) Emotional Support Short Form v2.0 Score(Baseline, Month 6)
  • Change in Mediterranean Dietary Screener (MEDAS) - Sugary Drinks Score(Baseline, Month 6)
  • Change in Diabetes-Specific Support Score(Baseline, Month 6)
  • Change in Diabetes Distress Scale Score(Baseline, Month 6)

Study Sites (1)

Loading locations...

Similar Trials